Vorinostat-polymer conjugate nanoparticles for acid-responsive delivery and passive tumor targeting

Biomacromolecules

Volumn 15, Issue 12, 2014, Pages 4534-4543

  Denis, Iza ^a,b,c   El Bahhaj, Fatima ^b   Collette, Floraine ^b   Delatouche, Régis ^b   Gueugnon, Fabien ^a,b,c   Pouliquen, Daniel ^a,b,c   Pichavant, Loic ^b   Héroguez, Valérie ^b   Grégoire, Marc ^a,b,c   Bertrand, Philippe ^b,d   Blanquart, Christophe ^a,b,c,d  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d Laboratoire de Chimie des Polymères Organiques CNRS UMR 5629 Bordeaux ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

RING OPENING POLYMERIZATION;

CELLULAR INTERNALIZATION; DELIVERY SYSTEMS; HISTONE DEACETYLASES; POLYMER CONJUGATE; RING OPENING METATHESIS POLYMERIZATION; SELECTIVE DISTRIBUTION; STEALTH PROPERTY; TUMOR TARGETING;

TUMORS;

ALKYNE; AZIDOMACROMONOMER; HISTONE DEACETYLASE; MACROMONOMER; NANOCARRIER; POLYMER; RHODAMINE; UNCLASSIFIED DRUG; VORINOSTAT; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; CHEMISTRY; CLICK CHEMISTRY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; HISTONE ACETYLATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERNALIZATION; MESOTHELIOMA; MOUSE; NONHUMAN; PH; POLYMERIZATION; RING OPENING METATHESIS POLYMERIZATION; ANIMAL; APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; GENETIC TRANSFECTION; HUMAN; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CLICK CHEMISTRY; DRUG DELIVERY SYSTEMS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROXAMIC ACIDS; MESOTHELIOMA; MICE; MICE, NUDE; NANOPARTICLES; POLYMERS; TRANSFECTION;

EID: 84916614226     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm501338r     Document Type: Article

References (25)

1. Duvic, M.; Vu, J. Expert Opin. Invest. Drugs 2007, 16, 1111
2. Richon, V. M.; Webb, Y.; Merger, R.; Sheppard, T.; Jursic, B.; Ngo, L.; Civoli, F.; Breslow, R.; Rifkind, R. A.; Marks, P. A. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5705
3. Butler, L. M.; Agus, D. B.; Scher, H. L.; Higgins, B.; Rose, A.; Cordon-Cardo, C.; Thaler, H. T. R.; Rifkind, A.; Marks, P. A.; Richon, V. M. Cancer Res. 2000, 60, 5165
4. Martinet, N.; Bertrand, P. Cancer Manag. Res. 2011, 3, 117
5. Peart, M. J.; Smyth, G. K.; Rvan Laar, K.; Bowtell, D. D.; Richon, V. M.; Marks, P. A.; Holloway, A. J.; Johnstone, R. W. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 3697
6. Flipo, M.; Charton, J.; Hocine, A.; Dassonneville, S.; Deprez, B.; Deprez-Poulain, R. J. Med. Chem. 2009, 52, 6790
7. Du, L.; Musson, D. G.; Wang, A. Q. J. Pharm. Biomed. Anal. 2006, 42, 556
8. Parise, R. A.; Holleran, J. L.; Beuner, J. H.; Ramalingam, S.; Egorin, M. J. J. Chromatogr. B 2006, 840, 108
9. Dedes, K. J.; Dedes, I.; Imesch, P.; von Bueren, A. O.; Fink, D.; Fedier, A. Anticancer Drugs 2009, 20, 321
10. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nat. Nanotechnol. 2007, 2, 751
11. Zhang, L.; Gu, F. X.; Chan, J. M.; Wang, A. Z.; Langer, R. S.; Farokhzad, O. C. Clin. Pharmacol. Ther. 2008, 83, 761
12. Scita, G.; Di Fiore, P. P. Nature 2010, 463, 464
13. Modi, S.; Swetha, M. G.; Goswami, D.; Gupta, G. D.; Mayor, S.; Krishnan, Y. Nat. Nanotechnol. 2009, 4, 325
14. Sato, N. L.; Niimura, S.; Fujisawa, N.; Maeda, Y. Jpn. J. Pharmacol. 1986, 41, 163
15. el Bahhaj, F.; Dekker, F. J.; Martinet, N.; Bertrand, P. Drug Discovery Today 2014, 19, 1337
16. Hockly, E.; Richon, V. M.; Woodman, B.; Smith, D. L.; Zhou, X.; Rosa, E.; Sathasivam, K.; Ghazi-Noori, S.; Mahal, A.; Lowden, P. A.; Steffan, J. S.; Marsh, J. L.; Thompson, L. M.; Lewis, C. M.; Marks, P. A.; Bates, G. P. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 2041
17. Mohamed, E. A.; Zhao, Y.; Meshali, M. M.; Remsberg, C. M.; Borg, T. M.; Foda, A. M.; Takemoto, J. K.; Sayre, C. L.; Martinez, S. E.; Davies, N. M.; Forrest, M. L. J. Pharm. Sci. 2012, 101, 3787
18. Guillot, F.; Boutin, B.; Blanquart, C.; Fonteneau, J. F.; Robard, M.; Gregoire, M.; Pouliquen, D. Vaccine 2011, 29, 5534
19. Barbone, D.; Cheung, P.; Battula, S.; Busacca, S.; Gray, S. G.; Longley, D. B.; Bueno, R.; Sugarbaker, D. J.; Fennell, D. A.; Broaddus, V. C. PLoS One 2012, 7, e52753
20. Hurwitz, J. L.; Stasik, I.; Kerr, E. M.; Holohan, C.; Redmond, K. M.; McLaughlin, K. M.; Busacca, S.; Barbone, D.; Broaddus, V. C.; Gray, S. G.; O'Byrne, K. J.; Johnston, P. G.; Fennell, D. A.; Longley, D. B. Eur. J. Cancer 2012, 48, 1096
21. Vandermeers, F.; Sriramareddy, S. N.; Costa, C.; Hubaux, R.; Cosse, J.-P.; Willems, L. Lung Cancer 2013, 81, 311
22. Delatouche, R.; Denis, I.; Grinda, M.; el Bahhaj, F.; Baucher, E.; Collette, F.; Héroguez, V.; Gregoire, M.; Blanquart, C.; Bertrand, P. Eur. J. Pharm. Biopharm. 2013, 85, 862
23. Collette, F.; Delatouche, R.; Blanquart, C.; Gueugnon, F.; Grégoire, M.; Bertrand, P.; Héroguez, V. J. Polym. Sci., Part A: Polym. Chem. 2013, 51, 176
24. Gueugnon, F.; Denis, I.; Pouliquen, D.; Collette, F.; Delatouche, R.; Héroguez, V.; Gregoire, M.; Bertrand, P.; Blanquart, C. Biomacromolecules 2013, 14, 2396
25. Blanquart, C.; Francois, M.; Charrier, C.; Bertrand, P.; Gregoire, M. Curr. Cancer Drug Targets 2011, 11, 919